Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NR2F2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
EPCAM - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
COCH - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CENPV - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SPINT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BIK - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RIMS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM101B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM169A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
THEMIS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
E2F7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PEG3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BTBD6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC6A15 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
QPCT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM174B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HTR2C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PLXND1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DIP2C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on